Prenetics Global CEO Touts IM8 Breakout Growth, Guides $180M-$200M Revenue at Conference

1 hour ago 1

MarketBeat

Sat, March 21, 2026 astatine 3:02 PM CDT 6 min read

Prenetics Global logo

IM8 drove a breakout year: Prenetics reported astir $92M successful 2025 gross portion its IM8 DTC supplements marque reached $120M ARR, scaled from ~$581k first-month gross to ~$10M monthly by Dec‑2025 and ended the twelvemonth astatine 63% gross margin; absorption guides $180M–$200M for 2026 and expects gross margins astatine oregon supra 60%.
Portfolio simplification and beardown liquidity: Management sold non-core assets (ACT, Europa, Insighta) to absorption connected IM8, has astir $160M successful liquid assets, zero debt, and says it has a wide roadmap to profitability by Q4‑2027 (ACT merchantability $72M with ~$46M received, Insighta ~$70M cash).
Capital-allocation moves and hazard posture: Prenetics holds astir 510 Bitcoin (has stopped buying) and announced a $40M stock buyback (total up to $42.75M including insider purchases), portion readying dense selling concern (about 45–50% of revenue) and 3 objective trials including 1 with the Mayo Clinic.
Interested successful Prenetics Global Limited? Here are 5 stocks we similar better.

Invest successful Gold

Prenetics Global (NASDAQ:PRE) CEO and co-founder Danny Yeung told investors the institution delivered what helium described arsenic a “breakout maturation story” successful 2025, driven by the accelerated enlargement of its IM8 direct-to-consumer supplements concern and a broader strategical displacement to absorption connected that brand.

Yeung said Prenetics generated astir $92 cardinal successful full-year 2025 revenue, inclusive of aggregate concern units. He attributed the results mostly to IM8, which helium said reached $120 cardinal successful yearly recurring gross (ARR) successful its archetypal afloat twelvemonth of operations and ended 2025 astatine 63% gross margins.

→ Forget Chipmakers: Walmart and Target Are the Real AI Plays

According to Yeung, IM8 launched successful December 2024 and scaled quickly. He said the brand’s first-month gross was astir $581,000 and grew to $10 cardinal successful monthly revenue by December 2025. He characterized the maturation arsenic unusually accelerated for the vitamins and supplements category.

Yeung said Prenetics has divested non-core assets to ore connected IM8 and believes it present has “a precise wide roadmap to profitability by Q4 of 2027.” He besides emphasized the company’s liquidity position, stating Prenetics has astir $160 cardinal successful liquid assets and zero debt.

→ Expedia Stock Turns Volatile After Rally. Where Does It Go Next?

He outlined respective transactions completed arsenic portion of the portfolio simplification:

ACT was sold successful October for $72 cardinal successful cash, and Yeung said Prenetics received astir $46 million of that amount.
Europa was sold successful an all-stock transaction for up to $13 million.
The institution sold its full involvement successful Insighta to Tencent for $70 cardinal successful cash, which Yeung said occurred “last month.”